These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 21903516)

  • 1. Botulinum toxin (Botox, Dysport, and Myobloc): pharmacology 101.
    Wynn RL
    Gen Dent; 2011; 59(2):88-90. PubMed ID: 21903516
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of botulinum neurotoxin preparations for the treatment of cervical dystonia.
    Chapman MA; Barron R; Tanis DC; Gill CE; Charles PD
    Clin Ther; 2007 Jul; 29(7):1325-37. PubMed ID: 17825685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin type A and type B for sialorrhoea in Parkinson's disease: a case for switching therapy?
    Santamato A; Panza F; Solfrizzi V; Frisardi V; Ranieri M; Fiore P
    J Rehabil Med; 2008 Nov; 40(10):882-3. PubMed ID: 19242630
    [No Abstract]   [Full Text] [Related]  

  • 4. Botulinum toxin type A vs type B for axillary hyperhidrosis in a case series of patients observed for 6 months.
    Frasson E; Brigo F; Acler M; Didonè G; Vicentini S; Bertolasi L
    Arch Dermatol; 2011 Jan; 147(1):122-3. PubMed ID: 21242408
    [No Abstract]   [Full Text] [Related]  

  • 5. Safety of botulinum toxin therapies.
    Madalinski MH; Slawek J
    Dis Colon Rectum; 2003 Dec; 46(12):1719-20. PubMed ID: 14668605
    [No Abstract]   [Full Text] [Related]  

  • 6. Same-patient prospective comparison of Botox versus Dysport for the treatment of primary axillary hyperhidrosis and review of literature.
    Vergilis-Kalner IJ
    J Drugs Dermatol; 2011 Sep; 10(9):1013-5. PubMed ID: 22052270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Different botulinum toxins and their specifications].
    Beylot C
    Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S77-85. PubMed ID: 19576490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin therapy of hemifacial spasm: comparing different therapeutic preparations.
    Frei K; Truong DD; Dressler D
    Eur J Neurol; 2006 Feb; 13 Suppl 1():30-5. PubMed ID: 16417595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin in blepharospasm and oromandibular dystonia: comparing different botulinum toxin preparations.
    Bhidayasiri R; Cardoso F; Truong DD
    Eur J Neurol; 2006 Feb; 13 Suppl 1():21-9. PubMed ID: 16417594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic botulinum type A toxin complex (Dysport®) for migraine without aura.
    Chankrachang S; Arayawichanont A; Poungvarin N; Nidhinandana S; Boonkongchuen P; Towanabut S; Sithinamsuwan P; Kongsaengdao S
    Headache; 2011 Jan; 51(1):52-63. PubMed ID: 21083558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological aspects of Botox, Dysport and Myobloc/NeuroBloc.
    Dressler D; Hallett M
    Eur J Neurol; 2006 Feb; 13 Suppl 1():11-5. PubMed ID: 16417592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin A (Botox) and sweating-dose efficacy and comparison to other BoNT preparations.
    Schlereth T; Mouka I; Eisenbarth G; Winterholler M; Birklein F
    Auton Neurosci; 2005 Feb; 117(2):120-6. PubMed ID: 15664565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early communication about an ongoing safety review Botox and Botox Cosmetic (botulinum toxin type A) and Myobloc (botulinum toxin type B).
    U.S. Food and Drug Administration
    Plast Surg Nurs; 2008; 28(3):150-1. PubMed ID: 18794742
    [No Abstract]   [Full Text] [Related]  

  • 14. Botulinum toxin products overview.
    Carruthers A; Carruthers J
    Skin Therapy Lett; 2008; 13(6):1-4. PubMed ID: 18806905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic adverse effects after botulinum toxin type B (myobloc) injections for the treatment of palmar hyperhidrosis.
    Baumann LS; Halem ML
    Arch Dermatol; 2003 Feb; 139(2):226-7. PubMed ID: 12588237
    [No Abstract]   [Full Text] [Related]  

  • 16. Botox: beyond wrinkles.
    Carruthers J; Carruthers A
    Clin Dermatol; 2004; 22(1):89-93. PubMed ID: 15158551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Do not say more Botox!].
    Junod V
    Rev Med Suisse; 2012 Feb; 8(326):288-9. PubMed ID: 22364079
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacology of botulinum toxin: differences between type A preparations.
    Rosales RL; Bigalke H; Dressler D
    Eur J Neurol; 2006 Feb; 13 Suppl 1():2-10. PubMed ID: 16417591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin therapy for cervical dystonia.
    Jankovic J
    Neurotox Res; 2006 Apr; 9(2-3):145-8. PubMed ID: 16785112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Commentary: Botulinum toxin in clinical medicine: part II.
    Benedetto AV
    Clin Dermatol; 2004; 22(1):1-2. PubMed ID: 15158537
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 25.